- Home
- MAMK vs HOWL Comparison
MAMK vs HOWL Comparison
Compare MAMK & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMK
- HOWL
- Stock Information
- Founded
- MAMK 2007
- HOWL 2017
- Country
- MAMK China
- HOWL United States
- Employees
- MAMK N/A
- HOWL N/A
- Industry
- MAMK Apparel
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- MAMK Consumer Discretionary
- HOWL Health Care
- Exchange
- MAMK Nasdaq
- HOWL Nasdaq
- Market Cap
- MAMK 43.2M
- HOWL 47.1M
- IPO Year
- MAMK 2025
- HOWL 2021
- Fundamental
- Price
- MAMK $2.16
- HOWL $1.33
- Analyst Decision
- MAMK
- HOWL Strong Buy
- Analyst Count
- MAMK 0
- HOWL 5
- Target Price
- MAMK N/A
- HOWL $7.20
- AVG Volume (30 Days)
- MAMK 92.8K
- HOWL 131.2K
- Earning Date
- MAMK 01-01-0001
- HOWL 08-14-2025
- Dividend Yield
- MAMK N/A
- HOWL N/A
- EPS Growth
- MAMK N/A
- HOWL N/A
- EPS
- MAMK 0.12
- HOWL N/A
- Revenue
- MAMK $21,434,100.00
- HOWL N/A
- Revenue This Year
- MAMK N/A
- HOWL N/A
- Revenue Next Year
- MAMK N/A
- HOWL N/A
- P/E Ratio
- MAMK $17.87
- HOWL N/A
- Revenue Growth
- MAMK N/A
- HOWL N/A
- 52 Week Low
- MAMK $1.87
- HOWL $0.60
- 52 Week High
- MAMK $4.00
- HOWL $4.18
- Technical
- Relative Strength Index (RSI)
- MAMK N/A
- HOWL 61.03
- Support Level
- MAMK N/A
- HOWL $1.20
- Resistance Level
- MAMK N/A
- HOWL $1.41
- Average True Range (ATR)
- MAMK 0.00
- HOWL 0.08
- MACD
- MAMK 0.00
- HOWL 0.01
- Stochastic Oscillator
- MAMK 0.00
- HOWL 93.88
About MAMK MaxsMaking Inc. Class A Ordinary Shares
MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.